Target intelligence / Profile preview

MicroRNA 4495 (MIR4495)

Target
MIR4495
Molecular classification
Non-coding RNA, microRNA, Other
01

Overview

MicroRNA 4495 (MIR4495) is a short, non-coding RNA molecule classified as a microRNA, typically 20–24 nucleotides in length, involved in the post-transcriptional regulation of gene expression in multicellular organisms[1]. Like other microRNAs, MIR4495 functions by incorporating into the RNA-induced silencing complex (RISC) and binding to target mRNAs, most commonly leading to suppression of translation or mRNA destabilization. MIR4495 is not a protein-coding gene nor a conventional therapeutic target such as a receptor or an enzyme, but may regulate protein-coding genes indirectly. While many microRNAs have established disease roles or biomarker potential, there is currently no documented, specific biological role or disease association for MIR4495 in the available literature[1][3]. Its classification as a miRNA suggests it participates in diverse cellular and regulatory processes common to this RNA class.

Other names
hsa-mir-4495MIR4495
02

Mechanism of action

N/A for direct pharmacological targeting (miRNAs are regulated rather than directly targeted by classic drugs; antisense oligonucleotides and similar modalities may regulate miRNA function in principle, but no drugs specifically for MIR4495 are documented)

03

Biological functions

Post-transcriptional gene silencingRegulation of mRNA stabilityRegulation of mRNA translationPossible roles in cell proliferation, differentiation, and apoptosis (for the miRNA class overall)[1][3][4]
04

Disease associations

Other (miRNAs, in general, have roles in cancer, inflammation, and other diseases, but there is currently no documented specific disease association for MIR4495 in the provided sources)
05

Safety considerations

N/A (no safety or therapeutic challenges specific to MIR4495 are documented; generally, miRNA modulation can have broad, pleiotropic effects due to the large regulatory networks involved)[3][4]
06

Biomarkers

Potential biomarker (circulating miRNAs are explored as biomarkers in various diseases generally, but specific evidence for MIR4495 as a validated biomarker is not currently available)[3]

Beyond the preview

Go deeper on MicroRNA 4495 (MIR4495).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 4495 (MIR4495).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call